Our follow-up study revealed that high plasma level of lncRNA POU3F3 may serve as a biomarker for the poor prognosis of nasopharyngeal carcinoma, which may provide guidance for clinical studies. Here, POU3F3 is linked to nasopharyngeal carcinoma.